 |
The latest news from the Hope Center. Please e-mail us with additions: hopecenter@neuro.wustl.edu.
|
Hope Center Profile: James Galvin, MD, MPHJames Galvin, MD, MPH, always wanted to be a doctor. But it was his father's own battle with Parkinson's disease that convinced the New Jersey native to become a neurologist. Galvin's research at the Hope Center seeks better treatments for people with neurodegenerative diseases like Alzheimer's and Parkinson's. Read More > Connecting the Dots on Early Diagnosis of Alzheimer's DiseaseThe ability to remember word lists and other tests of episodic memory are commonly used to detect early signs of Alzheimer's disease. But Hope Center investigator James Galvin, MD, MPH, may have found a way of detecting the mental changes associated with Alzheimer's Disease years earlier. Read More > New ALS Mouse Model Closely Resembles "Typical" ALSLike humans with ALS, the new mouse engineered by Hope Center investigator Robert Baloh, MD, PhD, develops progressive paralysis; loses muscle mass and motor neurons, and eventually dies of the disorder. These similarities to human ALS make it an exceptional model for developing and testing new treatments for human ALS. Read More > |
|
|
|
|
Hope Center Profile: James Galvin, MD, MPHJames Galvin, MD, MPH, always wanted to be a doctor. But it was his father's own battle with Parkinson's disease that convinced the New Jersey native to become a neurologist. Galvin's research at the Hope Center seeks better treatments for people with neurodegenerative diseases like Alzheimer's and Parkinson's. Read More > Connecting the Dots on Early Diagnosis of Alzheimer's DiseaseThe ability to remember word lists and other tests of episodic memory are commonly used to detect early signs of Alzheimer's disease. But Hope Center investigator James Galvin, MD, MPH, may have found a way of detecting the mental changes associated with Alzheimer's Disease years earlier. Read More > New ALS Mouse Model Closely Resembles "Typical" ALSLike humans with ALS, the new mouse engineered by Hope Center investigator Robert Baloh, MD, PhD, develops progressive paralysis; loses muscle mass and motor neurons, and eventually dies of the disorder. These similarities to human ALS make it an exceptional model for developing and testing new treatments for human ALS. Read More > Sleep Loss Worsens Alzheimer's and May Play at Role in OnsetNeurodegenerative disorders like Alzheimer's disease and Parkinson's disease often disrupt sleep. New findings from the lab of David Holtzman, M.D., are some of the first indications that sleep loss could play a role in the genesis of such disorders. Holtzman is a Hope Center researcher and steering committee member. Read More > Restoring Ability: Treatments for Nerve-Damage LimbsHope Center researcher Susan Mackinnon, MD, and Justin Brown, MD, are using newly developed nerve grafting and nerve transfer techniques to help patients of the Center for Nerve Injury and Paralysis regain movement and sensation in their nerve-damaged limbs. Read More > Online Infantile Spasms Registry CreatedHope Center researchers Christina Gurnett, M.D., Ph.D. and Liu Lin Thio, M.D., Ph.D., are part of a group of researchers and clinicians who have created the first-ever registry to track a severe type of epilepsy that strikes infants within their first few months of life. Read More > Cells have their own biological clocksGraduate fellow Alexis Webb, working with Hope Center researcher Erik Herzog, Ph.D. and others, has shown that individual cells keep time on their own - even when isolated from the body's biological clock. Read More > Tracing Molecular MisstepsPart of the work of biophysicist Rohit V . Pappu, PhD, concentrates on how proteins clump together. This research is relevant to Huntington’s disease — which affects balance, speech and muscle strength, and typically causes death within 20 years — as well as eight other inherited neurodegenerative diseases . Read More > Robotics to speed chemical analysis2006 - The introduction of Marvin, a chemical-analyzing robot, to the Mallinckrodt Institute of Radiology's Molecular Imaging Center by Helen Piwinica-Worms, Ph.D. and Hope Center members Raphael Kopan, Ph.D., and David Piwinica-Worms, M.D. Ph.D. Read More > Philip Bayly studies brain's elastic propertiesAugust 11, 2005 - How exactly does the human brain react to a fall or an automobile accident? The Hope Center's Dr. Philip Bayly is working to answer that question, using strapped-in volunteers and a new computer model based on magnetic resonance imaging (MRI) data. Read More > Meet Tim Miller: Director of the Hobler Lab for ALS ResearchElisa Reeves of Hope Happens interviewed Dr. Timothy Miller, MD/PhD, Assistant Professor of Neurology at Washington University School of Medicine, about joining the Hope Center faculty and his ALS research. Miller is the first director of the Christopher Wells Hobler Laboratory for ALS Research. Read More > Janice Brunstrom applies new approaches to cerebral palsyHope Center faculty member Janice Brunstrom, M.D. has fought many battles in her life, but her greatest cause may be correcting common misconceptions about cerebral palsy. Dr. Brunstrom is associate professor of neurology and pediatrics and director of the Pediatric Neurology Cerebral Palsy Center at St. Louis Children's Hospital and Washington University School of Medicine. Read More > In pursuit of brain and spinal cord repairValeria Cavalli, PhD, a specialist in neuronal cell biology and axon injury, is engaged with one of medicine’s great challenges: to reverse paralysis and restore nerve function when the central nervous system (CNS) has been severely damaged by stroke, spinal-cord injury or disease. Read More > Hope Center researchers measure Alzheimer's protein in HumansResearchers have known since the early 20th century that a characteristic sign of Alzheimer’s disease is that it leaves sufferers’ brains riddled with plaques. The key ingredient of the plaques is a fragment of a protein known as amyloid precursor protein (APP). The fragment itself is called amyloid beta (Aβ). The causes of excessive Aβ are often maddeningly elusive. That’s partially because a wealth of environmental and genetic factors probably contribute to risk. But another significant question also obsc Read More > Hope Center profiled in Washington University MagazineSpring 2006 — Research at the Hope Center for Neurological Disorders, supported by Hope Happens (formerly ALS Hope,) provides new hope for patients suffering from Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease,) Alzheimer's, Multiple Sclerosis, and other degenerative neurological disorders through multi-disciplinary, team-oriented approach. Read More > Harris and True-Krob study disease-causing prion proteinsPrions are a new kind of infectious agent thought to be at the heart of several rare neurodegenerative disorders that devastate the brains of humans, cows and sheep. Hope Center members David Harris, M.D., Ph.D. and Heather True-Krob, Ph.D. are gathering new insights into how prions form and cause disease. As they do, tantalizing hints are starting to emerge that prions may be connected to a much wider range of biological phenomena than the rare brain disorders that first led to their discovery. Read More > Scratch no more: Gene for itch sensation discoveredJuly 25, 2007 -- Itching for a better anti-itch remedy? Your wish may soon be granted now that scientists at Washington University School of Medicine in St. Louis have identified the first gene for the itch sensation in the central nervous system. The discovery could rapidly lead to new treatments directly targeting itchiness and providing relief for chronic and severe itching. Read More > Alzheimer's genetics expert Goate turns to ALSA member of the Departments of Psychiatry and Genetics at Washington University School of Medicine since 1992, Alison Goate, Ph.D. is the Samuel and Mae S. Ludwig Professor of Genetics in Psychiatry and professor of genetics and of neurology. Her 16-person lab is devoted to genetic research on Alzheimer's disease (AD), tauopathies, and alcoholism—and since January 2005, the molecular underpinnings of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease. Read More > Tracking a gene mutation to treat its effectsRobert H. Baloh, MD, PhD, deciphers the molecular mechanics of neurodegenerative disease. Two of his research focuses are amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and Charcot- Marie-Tooth disease (CMT). Read More > Alex Evers studies mechanisms of anesthetic effectsHope Center member Alex S. Evers, M.D., wears a number of hats. He is the Henry E. Mallinckrodt Professor and head of the Department of Anesthesiology and a professor of medicine and of molecular biology and pharmacology. Most of Evers' career has involved looking at how lipid-like drugs can be used in anesthesia. For the past several years, he has focused on a particular class of lipid-like drugs: steroids. Read More > TransMed Partnership Forum (September 9-11)Join us in St. Louis, September 9-11, for the first annual TransMed Partnership Forum, a unique event focusing on translational medicine. The Forum will bring together the leading developers of breakthrough medical technologies in various disease fields, industry experts in translational medicine, investors, and the leading disease-focused foundations supporting biomedical research. Read More > Synapses Journal Club: First meeting January 11, 2008The Synapses Journal Club has adopted a “Synapses and Disease” focus for the last three academic semesters, and we anticipate that this will continue for at least the upcoming semester. We welcome investigators with an interest in this topic. Historically the club has had a somewhat electrophysiological focus, but more recently we have expanded with the interests of attendees to include cell biology, molecular biology, development, genetic models, etc. A list of last semester’s papers and the first schedul Read More > Neurobiology of Disease course: Begins January 17, 2008Neurobiology of Disease (Bio 5663) – an advanced graduate course on the pathology of nervous system disorders – will be offered Jan. 17 - May 1, 2008. Intended to acquaint neuroscience graduates with a broad spectrum of neurological diseases, each class session will be led by Washington University faculty members with expertise in topics such as neurooncology, stroke, retinal disease, perinatal brain injury, neurodegenerative disorders, neuroinflammation, epilepsy, and psychiatric disorders. Class sessions Read More > Hope Center Awards Competition: Deadline April 9, 2008The Hope Center for Neurological Disorders is pleased to announce that we are accepting applications for the
Hope Center Awards Competition. Awards of $1000 each will be given to one pre-doctoral student and one postdoctoral trainee whose work best fulfills the mission of the Hope Center: To improve the lives of those
with neurological diseases through basic research that advances scientific knowledge, treatment, recovery,
and cure. Read More > DEADLINES EXTENDED: Collaborative ALS Drug Discovery Initiative [7/18/08]Collaborative ALS Drug Discovery Initiative
Thanks to generous support from Project ALS, the ALS Therapy Alliance, and private donors, the Harvard NeuroDiscovery Center is pleased to announce the launch of the Collaborative ALS Drug Discovery Initiative, a major new program of early stage ALS drug discovery that combines biological and mechanistic expertise of investigators around the world
with our dedicated drug discovery team. Read More > 4th Annual Evening of Hope - May 14, 2008The fourth annual Hope Happens “Evening of Hope” will star world-famous violinist Anne Akiko Meyers, “Goddess of Fire,” in an exclusive performance. The evening will begin with cocktails, dinner at 6:30 p.m., and the concert at 8:00 p.m., followed by a reception with the artist at 9 p.m. Read More > Bear Cub Fund Grants [Applications due 9/15/08]The University Bear Cub Fund is soliciting grant applications from University researchers who want to move inventions from their laboratories toward commercialization. The Bear Cub Fund was established in 2002 and is administered through the University's research office. Approximately $200,000 in grant funds will be allocated to Washington University scientists each year. Read More > 2008 Hope Center Research Projects - Call for Proposals [10/15/08 deadline]The Hope Center for Neurological Disorders has funds available to support interdisciplinary projects which advance
the translational neuroscience goals of the Hope Center. Faculty may request up to $100,000 for one-year projects
to begin December 1, 2008. At least two projects will be awarded initially, with additional awards possible as funding becomes available Read More > Danforth Foundation donates $10 million for brain disease researchSt. Louis, Dec. 4, 2008 — The Danforth Foundation has granted the Hope Center for Neurological Disorders at Washington University School of Medicine in St. Louis a $10 million endowed matching gift for research into a range of conditions that cause injury and impairment to the brain and central nervous system. Read More > Brain-fluid sampling gives glimpse into Alzheimer's DiseaseA team led by researchers at Washington University School of Medicine in St. Louis, in collaboration with researchers at Eli Lilly and Co. in Indianapolis, have developed a new technique that, for the first time, provides a way to dynamically study proteins known to be related to Alzheimer’s disease in the fluid between brain cells, called interstitial fluid. Read More > Vonk's widow donates sculpture to Hope CenterSummer 2005 — Artist Jesse Vonk, widow of the late St. Louis Symphony Conductor Hans Vonk, has donated a stone and metal sculpture, In Shadow Of The Rock, to the Hope Center in his memory. Mr. Vonk, a beloved figure who took over the St. Louis Symphony from Leonard Slatkin when Mr. Slatkin moved to the National Symphony Orchestra in Washington , D.C., was treated at Washington University Medical Center for the Lou Gehrig's Disease that ultiamtely took his life. Read More > Molecular pump may help Alzheimer's patientsOct. 20, 2005 — A molecule that has long been an obstacle to cancer chemotherapy and drug treatments for brain disorders may soon become an ally in the fight against Alzheimer's disease, according to researchers at Washington University School of Medicine in St. Louis and the University of Rochester. Read More > Mark Goldberg is Clinical Lecturer Of the YearDecember 2, 2005 — When Washington University School of Medicine students honored faculty at the Distinguished Service Teaching Awards ceremony November 21, Hope Center Director Mark P. Goldberg, M.D. was the class of 2006's pick for "Clinical Lecturer of the Year." Read More > Light-sensing cells in retina develop before visionDec. 21, 2005 — Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision. The discovery should help scientists learn more about the eye's non-visual functions such as the synchronization of the body's internal, circadian clock, the pupil's responses to light and light-regulated release of hormones. Read More > Imaging breakthrough may help predict Alzheimer'sNov. 18, 2005: A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward techniques for diagnosing Alzheimer's disease before its clinical symptoms become apparent. Read More > Fox Foundation backs trial of protein discovered by Hope Center researchersThe Michael J. Fox Foundation for Parkinson's Research (MJFF) announced a grant of approximately $370,000 over three years to Ceregene, Inc., a biotechnology company based in San Diego, that will partially fund the first clinical trials for CERE-120, a breakthrough gene therapy product shown to slow or stop progression of Parkinson's disease in pre-clinical trials. Read More > Randall Bateman develops test to monitor Alzheimer'sA team led by Hope Center members Randall Bateman and David Holtzman, the Andrew B. and Gretchen P. Jones Professor of Neurology, has developed a test to monitor amyloid beta peptide, the long-suspected cause of Alzheimer's Disease, in humans for the first time. Read More > New Hope Center web site debutsWe are delighted to announce a major redesign of the Hope Center web site. The new site uses a "content management system" web design, which allows flexible, modular, and collaborative programming. Read More > New approaches to protect brains of premature infantsApril 11, 2007 -- A study of how the brain of a premature infant responds to injury has found vulnerabilities similar to those in the mature brain but also identified at least one significant difference, according to neuroscientists and neonatologists at Washington University School of Medicine in St. Louis. Read More > Hope Center investigators identify genetic variants that influence the onset of Alzheimer’s symptomsNeurofibrillary tangles are a hallmark of Alzheimer's disease. These tangles are made up of tau, a microtubule-associated protein that normally is found in nerve cells but which aggregates in patients with Alzheimer’s. A collaboration involving Hope Center investigators Alison Goate, John Kauwe, Anne Fagan, and David Holtzman found that DNA sequence variations in the tau gene are associated with early onset of Alzheimer's disease symptoms. Read More > Dave Holtzman receives prestigious MetLife AwardFeb. 23, 2007 -- David M. Holtzman, M.D., the Andrew B. and Gretchen P. Jones Professor and head of Neurology, is co-recipient of the MetLife Foundation Award for Medical Research in Alzheimer's Disease. Holtzman is also associate director of the Alzheimer's Disease Research Center (ADRC) and a member of the Hope Center for Neurological Disorders at Washington University School of Medicine in St. Louis. Read More > Carl Frieden honored by Protein SocietyHope Center investigator, Carl Frieden, Ph.D, will receive the 2007 Christian B. Anfinsen Award at the 21st Symposium of the Protein Society July 21-25 in Boston. Dr. Frieden is professor of biochemistry and of molecular biophysics. Read More > Taking the Chronic Out of Chronic PainPain warns us when our body is injured, but when pain becomes chronic, it loses all usefulness and becomes debilitating. Typically, pain killers block pain receptors. But Hope Center investigator Rob Gereau is approaching the problem from a new angle: What if you could reverse the process that makes pain chronic? Read More > Two New Genes for Alzheimer's Risk DiscoveredHope Center researcher Alison Goate, D. Phil., was one of an international team of scientists behind a new study that pooled DNA samples of 7,000 people with Alzheimer's Disease and 12,000 with no symptoms to identify genetic risk factors for the disease. Read More > Stroke Trials Registry hits 1000 entries!What stroke interventions are being tested in humans? Are there promising treatments on the horizon? For answers, one might check the Stroke Trials Registry hosted by the Internet Stroke Center. The Registry recently achieved a notable benchmark - 1000 entries. Read More > Life, Death, and the Renewal of the Neuron: Symposium honors Eugene Johnson, Jr., Ph.D."Life, Death, and the Renewal of the Neuron: The Leap from Bench to Bedside" took place on February 29th, 2008, at the Eric P. Newman Education Center on the campus of Washington University School of Medicine. This one-day Symposium was a celebration of the career of Eugene M. Johnson, Jr., Ph.D., Professor of Neurology, and Molecular Biology and Pharmacology. Read More > Treatment of epilepsy linked to high-fat, low-carbohydrate dietJanuary 2008 -- A recent study undertaken by a research team including Hope Center researchers Kelvin A. Yamada, Liu Lin Thio, and Michael Wong revealed that dietary changes to increase leptin levels, intranasal delivery of leptin, or pharmacological targeting of JAK2/PI3K signaling pathways may reduce the
length and frequency of epileptic symptoms. Read More > Michael Wong mentors blue ribbon winnerLinghui Zeng, M.D., Ph.D. (right), a postdoctoral research associate in neurology, shows Michael Wong, M.D., Ph.D., assistant professor of neurology and Zeng's mentor, her winning poster titled "Rapamycin Prevents Epilepsy in a Mouse Model of Tuberous Sclerosis Complex" at the 2008 Postdoc Scientific Symposium poster session at the Eric P. Newman Education Center. Read More > Leonard Berg Symposium on protein folding disorders (September 28-29)Mark your calendar for the 7th Annual Leonard Berg Symposium, to be held at Washington University September 28-29, 2007. The focus for this year's meeting is "Novel Approaches to Protein Misfolding Disorders." Abnormalities in protein folding and aggregation lead to pathology in most neurodegenerative disorders. This is one of the two scientific themes of the Hope Center for Neurological Disorders, and the topic of the Hope Center's Biomed 21 Interdisciplinary Research Center. Read More > An Itch is but an ItchHope Center investigator Zhou-Feng Chen, Ph.D. has discovered nerve cells specific to itching - dispelling the common belief among scientists that itching is just a less intense version of pain. Read More > Hope Center investigators identify new ALS geneResearch conducted at the Hope Center for Neurological Disorders has linked a mutation in the TDP-43 gene to ALS. Senior researcher Nigel Cairns, Ph.D, says the discovery has implications for research and treatment of both inherited and sporadic forms of ALS. Read More > Dr. Crowder receives Brown ProfessorshipA Hope Center investigator, C. Michael Crowder M.D./Ph.D., has been named the new Brown Professor of Anesthesiology. Dr. Crowder's research investigates mechanisms of neuronal cell death after a hypoxic injury, such as a stroke. Read More > Drug may prevent seizures after brain injuryUsing the drug rapamycin, researchers in Hope Center investigator Michael Wong's lab prevented changes in the brains of rats that typically result from a seizure and can lead to seizures later on. Subsequent seizures in the treated rats decreased significantly. Read More > The Alzheimer's Project: View the Series OnlineWatch "The Alzheimer's Project" on your computer. The Alzheimer’s Project is a four-part HBO documentary film series on Alzheimer's Disease including the science and research, children touched by Alzheimer’s, and people with the disease and their caregivers. Read More > Pulling the Plug on Ailing Nerve CellsHope Center investigators Drs. Aaron DiAntonio and Jeffrey Milbrandt have indentified the first gene that "pulls the plug" on ailing nerve branches from within the cell, a discovery that could yield greater insight into the painful nerve condition known as neuropathy. Read More > Brain Builder: Familiar Enzyme Found to Have New RoleHope Center scientist Dr. Jeffrey Milbrandt and collaborators have discovered that an enzyme studied for years because of its potential connections to cancer, diabetes, heart disease, hypertension and stroke may also help to create and maintain the brain. Read More > Time crucial in stroke, say Mark Goldberg and Maurizio CorbettaJanuary 10, 2005 — Time is the most important factor when dealing with stroke, the third leading cause of death in the U.S. But before a person can get a loved one crucial medical treatment in time, he or she must know what signs to heed. WUSM physicians and stroke experts Mark Goldberg and Maurizio Corbetta discuss stroke and its symptoms in the following St. Louis Post-Dispatch article. Read More > Gurnett seeks genetic cause for musculoskeletal birth defectsHope Center scientist, Christina Gurnett, M.D., Ph.D., is a pediatric neurologist with expertise in genetics research for brain diseases such as epilepsy. In this work, she is collaborating with with Matthew Dobbs, M.D., associate professor of orthopaedic surgeryto establishs a DNA databank of musculoskeletal disorders. Read More > High rank for Washington University's neuroscience programThe Washington University Program in Neuroscience was ranked in the top 10 in the latest survey of graduate and professional programs from US News & World Report. Hope Center faculty member Dr. Karen O'Malley is co-director of the interdepartmental program, which is responsible for graduate training in neuroscience. Read More > Neurology academy awards Robert Baloh for nerve disorder researchRobert Baloh, M.D., Ph.D. has received the S. Weir Mitchell Award from the American Academy of Neurology, for work in the Hope Center for Neurological Disorders conducted with Jeffrey Milbrandt, M.D., Ph.D. The S. Weir Mitchell Award is presented annually for the best neuroscience project by a physician who has recently completed training in neurology. Dr. Baloh is an Instructor in the Department of Neurology, Hope Center, and the Neuromuscular Division. Read More > Evening of Hope Gala supports Hope Center researchThe third annual Evening of Hope Gala, May 14, 2007, starred world renowned pianist Misha Dichter appearing with concertmaster David Halen and members of the St. Louis Symphony Orchestra: Mike Chen (viola), Heidi Harris (violin) and Daniel Lee (cello). Read More > Dr. William Danforth accepts "Spirit of Hope" award, lauds Hope CenterDr. William H. Danforth, Chancellor Emeritus of Washington University, was presented with the inaugural Christopher Hobler Spirit of Hope Award at an Evening of Hope, a gala dinner and concert Monday, May 14, 2007 at Sheldon Concert Hall in St. Louis. The award from Hope Happens honors Dr. Danforth’s support of medical research of neurological diseases. Read More > Hope Happens co-founder Jean Hobler honored as a Woman of AchievementJean Maritz Hobler, a major philanthropist , the founder of the ALS Hope Foundation (now Hope Happens), as well as a board and committee member of numerous non-profit organizations in the St. Louis community, was honored for her tremendous volunteer efforts at the 52nd Annual Women of Achievement Luncheon on Tuesday May 15th at the Ritz Carlton in Clayton. Read More > Dennis Choi to lead neurosciences at Emory UniversityDr. Dennis Choi has been selected to lead two major neuroscience initiatives at Emory University in Atlanta, Georgia. Dr. Choi was Chair of the Department of Neurology at Washington University from 1991 until 2001. He was founding director of the Center for the Study of Nervous System Injury, which led in part to the creation of the Hope Center for Neurological Disorders in 2005. Read More > Beyond Ticks and Itches: Understanding Tourette’s SyndromeHope Center Scientist Dr. Brad Schlagger and his collaborators are examining the functional connections between different brain areas in individuals with Tourette’s. The discovery that these connections appear immature or irregular may eventually make it possible to treat the causes – rather than just the symptoms – of the disease. Read More > The Eyes Have It: New Diagnostic Tools for Multiple SclerosisHope Center Investigators Dr. Sheng-Kwei Song and Dr. Anne Cross have identified an imaging approach that can lead to earlier diagnosis of optic nerve inflammation in multiple sclerosis. In addition to helping with diagnosis and treatment, this finding could also lead to better assessment of MS attacks throughout the brain and spinal cord. Read More > Hope Center investigators link amyloid levels to recovery from brain injuryTraumatic brain injury (TBI) is linked to a higher risk of Alzheimer’s Disease. In exploring this relationship, Hope Center investigators including David L. Brody, M.D., Ph.D., Gregory J. Zipfel, M.D., and David M. Holtzman, M.D., monitored rapid changes in amyloid in TBI patients, and found that amyloid levels increase during recovery from TBI. Read More > Dave Holtzman elected to Institute of MedicineDavid M. Holtzman, M.D., the Andrew B. and Gretchen P. Jones Professor and Chair of Neurology, has been
elected to the Institute of Medicine of the National Academy of Sciences. Holtzman is among 65 newly elected medical scientists who will provide advice on matters of biomedical science, medicine, and health to policy-makers, health professionals, and the public at large. Read More > |
 |
|
|
Meet Tim Miller: Director of the Hobler Lab for ALS ResearchElisa Reeves of Hope Happens interviewed Dr. Timothy Miller, MD/PhD, Assistant Professor of Neurology at Washington University School of Medicine, about joining the Hope Center faculty and his ALS research. Miller is the first director of the Christopher Wells Hobler Laboratory for ALS Research. Read More > |
|
|
|
 |